Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
A proposed immune mechanism that potentially modifies or exacerbates neurodegenerative disease presentation in older adults has received considerable attention in the past decade, with recent studies demonstrating a strong link between pro-inflammatory markers and neurodegeneration. The overarching aim of the following review is to synthesize recent research that supports a possible relationship between inflammation and clinical features of neurodegenerative diseases, including risk of development, cognitive and clinical correlates, and progression of the specified diseases. Specific emphasis is placed on providing a temporal context for the association between inflammation and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 2×
“control) in inflammatory markers, evaluating anti-inflammatory interventions, or delineating the molecular basis of inflammation ( Blasko et al, 2004 ; Glass, Saijo, Winner, Marchetto, & Gage, 2010 ; Gorelick, 2010 ; McGeer & McGeer, 1995 ; Wyss-Coray & Mucke, 2002 ), but instead will be directed towards elucidating c…”
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · cited 2×
“…the molecular basis of inflammation (Blasko et al., 2004; Glass, Saijo, Winner, Marchetto, & Gage, 2010; Gorelick, 2010; McGeer & McGeer, 1995; Wyss-Coray & Mucke, 2002), but instead will be directed towards elucidating cognitive and neurobehavioral associations with inflammatory burden in…”
Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., & Schwartz, M. (2006) · Nature Neuroscience · doi:10.1038/nn1629 · Cited by 1,209 · cited 2×
“…studies have demonstrated that cytokines like Interleukin-1 (IL-1) not only facilitate long-term potentiation (LTP), but also contribute to the maintenance of hippocampal neurogenesis (Ekdahl, Kokaia, & Lindvall, 2009; Vitkovic, Bockaert, & Jacque, 2000; Yirmiya & Goshen, 2011; Ziv et al., 2006).”
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 2×
“…studies also confirm the presence of activated and reactive microglia, respectively, in the SNpc and striatum of PD patients (Block & Hong, 2007; Gerhard et al., 2006; McGeer & McGeer, 2008; Rogers et al., 2007); although these findings do not isolate a temporal course for inflammation and PD,…”
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 1×
“Furthermore, baseline levels of inflammatory markers (eg, TNF-α) have also been shown to predict an increased rate of cognitive deterioration in AD, as indexed by the ADAS-COG score ( Holmes et al, 2009 ).”
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 2×
“Although imaging studies that address inflammation and AD are sparse, isolated reports corroborate these findings and further suggest that activation of microglia occurs prior to evidence of cerebral atrophy in AD patients (Cagnin et al., 2001).”
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027 · cited 1×
“An older adult's infection history and specifically, their exposure to systemic inflammatory events are critically important to consider when evaluating the association between inflammation and clinical presentation ( Perry, Cunningham, & Holmes, 2007 ; Tang, Baranov et al, 2011 ; Zhu et al, 2000 ).”
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · cited 4×
“…and cognitive function (Dimopoulos et al., 2006; Komulainen et al., 2007; Marioni et al., 2009; Rafnsson et al., 2007; Weaver et al., 2002; Yaffe et al., 2003, 2004), although isolated studies suggest minimal to no relationship with cognitive decline (Alley, Crimmins, Karlamangla, Hu, &…”
InfluentialBrain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801
Tang, W., Lu, Y., Tian, Q.-Y., Zhang, Y., Guo, F.-J., Liu, G.-Y., Syed, N. M., Lai, Y., Lin, E. A., Kong, L., et al. (2011) · Science · doi:10.1126/science.1199214 · Cited by 761
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
Inflammatory markers and cognition in well-functioning African-American and white elders
Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706 · cited 1×
“…and cognitive function (Dimopoulos et al., 2006; Komulainen et al., 2007; Marioni et al., 2009; Rafnsson et al., 2007; Weaver et al., 2002; Yaffe et al., 2003, 2004), although isolated studies suggest minimal to no relationship with cognitive decline (Alley, Crimmins, Karlamangla, Hu, &…”
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · cited 2×
“In toxic mouse models of PD (i.e., MPTP models), increases in SNpc cytokine levels, particularly TNF-α, are observed and have been shown to be highly toxic to dopaminergic neurons (Letiembre et al., 2009; McGeer & McGeer, 2008; Przedborski, 2010; Rogers, Mastroeni, Leonard, Joyce, & Grover, 2007).”
Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.024 · Cited by 584 · cited 2×
“These studies provide a proxy means of assessing the role of delirium when superimposed on a neurodegenerative disorder, and points to increased vulnerability for acute and prolonged cognitive perturbation in animals with pre-existing pathology (Cunningham et al., 2009).”
Peripheral cytokines profile in parkinson’s disease
Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.003 · Cited by 547 · cited 2×
“…UPDRS), inflammatory cytokines (i.e., TNF-α; IL-6) and chemokines (i.e., RANTES) have been associated with functional disability (Menza et al., 2010; Reale et al., 2009; Rentzos et al., 2009; Scalzo, Kummer, Cardoso, & Teixeira, 2010), reduced gait speed (Scalzo et al., 2010), and depression…”
Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging
Weaver, J. D., Huang, M.-H., Albert, M., Harris, T., Rowe, J. W., & Seeman, T. E. (2002) · Neurology · doi:10.1212/wnl.59.3.371 · Cited by 536
“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
Intrathecal inflammation precedes development of Alzheimer's disease
Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · cited 3×
“…correlate with global cognitive performance in AD patients (i.e., MMSE), suggesting that worse overall cognition is associated with higher levels of peripheral inflammatory markers (Bonotis et al., 2008; Bossu et al., 2008; Forlenza et al., 2009; Licastro et al., 2000; Tarkowski et al., 2003).”
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
(2008) · Archives of Neurology · doi:10.1001/archneur.2008.65.7.nct70006 · Cited by 387 · cited 1×
“Thus, while preliminary analyses suggested that NSAIDs might induce a net cognitive decline in older adults (Martin et al., 2008), secondary analyses of CSF biomarkers indicated reduced rates of ongoing AD pathogenesis in asymptomatic participants treated with naproxen, particularly after 2–3 years.”
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374 · cited 4×
“…of altered cells, chronically activated microglia (i.e., innate immune cells in the brain) can also induce apoptosis in neighboring, functioning cells and decrease the production of neuroprotective hormones (Blasko et al., 2004; Eikelenboom, Rozemuller, & van Muiswinkel, 1998; Liu & Hong, 2003).”
InfluentialMicroglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
Gorelick, P. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05726.x · Cited by 361
Murray, C. A., & Lynch, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02974.1998 · Cited by 359
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group (2007) · Neurology · doi:10.1212/01.wnl.0000260269.93245.d2 · Cited by 354 · cited 1×
“…highlighted a reduced incidence of AD in NSAID users (McGeer, Rogers, & McGeer, 2006; in t’ Veld et al., 2001), results from clinical trials have been mixed, with many showing no effect of NSAID use on incident risk (Arvanitakis et al., 2008) or later development of AD (Lyketsos et al., 2007).”
Tarkowski, E., Blennow, K., Wallin, A., & Tarkowski, A. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020568013953 · Cited by 349
Systemic markers of inflammation and cognitive decline in old age
Schram, M. T., Euser, S. M., De Craen, A. J. M., Witteman, J. C., Frölich, M., Hofman, A., Jolles, J., Breteler, M. M. B., & Westendorp, R. G. J. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01159.x · Cited by 326 · cited 5×
“Factors such as ApoE4 status (Schram et al., 2007), metabolic syndrome (Yaffe et al., 2004), and degree of elevation in inflammatory markers (Dik et al., 2005) appear to influence the strength of this relationship; however, the specificity of cognitive domains affected and inflammatory mediators…”
InfluentialRogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease
Vehmas, A. K., Kawas, C. H., Stewart, W. F., & Troncoso, J. C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00090-8 · Cited by 230 · cited 1×
“Postmortem studies of patients with low Braak stages of AD pathology demonstrate colocalization of microglia and Abeta deposits ( Arends, Duyckaerts, Rozemuller, Eikelenboom, & Hauw, 2000 ; Hoozemans et al, 2006 ; Vehmas, Kawas, Stewart, & Troncoso, 2003 ).”
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., Schulz-Schaeffer, W., & Fassbender, K. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.018 · Cited by 228
Inflammatory changes parallel the early stages of Alzheimer disease
Parachikova, A., Agadjanyan, M. G., Cribbs, D. H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T. G., & Cotman, C. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.014 · Cited by 203
Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging
Ravaglia, G., Forti, P., Maioli, F., Chiappelli, M., Montesi, F., Tumini, E., Mariani, E., Licastro, F., & Patterson, C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.012 · Cited by 198 · cited 3×
“In contrast, other longitudinal studies have reported no association between inflammation and AD risk (Ravaglia et al., 2007; Sundelof et al., 2009).”
In vivo detection of microglial activation in frontotemporal dementia
Cagnin, A., Rossor, M., Sampson, E. L., MacKinnon, T., & Banati, R. B. (2004) · Annals of Neurology · doi:10.1002/ana.20332 · Cited by 187
Bermejo, P., Martín-Aragón, S., Benedí, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.02.002 · Cited by 178
Scalzo, P., Kümmer, A., Cardoso, F., & Teixeira, A. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.062 · Cited by 175
Systemic inflammation and delirium: important co-factors in the progression of dementia
Cunningham, C. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390945 · Cited by 153 · cited 2×
“…reports of frank, accelerated cognitive decline in older adults secondary to delirium are frequently discussed, objective evidence clearly suggests that episodes of delirium predict increased likelihood of dementia and institutionalization in older adults (Cunningham, 2011; Witlox et al., 2010).”
Inflammatory markers in AD and MCI patients with different biomarker profiles
Schuitemaker, A., Dik, M. G., Veerhuis, R., Scheltens, P., Schoonenboom, N. S. M., Hack, C. E., Blankenstein, M. A., & Jonker, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.014 · Cited by 149
Microglia, amyloid and dementia in Alzheimer disease
Arends, Y. M., Duyckaerts, C., Rozemuller, J. M., Eikelenboom, P., & Hauw, J.-J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00094-4 · Cited by 139
Sjogren, M. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.019422 · Cited by 125 · cited 3×
“…the mechanism by which inflammation affects neurodegeneration in bvFTD may stem from an early dysregulation of inflammatory mediators, particularly the TNF-α super family (Sjogren et al., 2004; Tang, Lu et al., 2011), rather than an induction of and/or response to misfolded protein aggregates.”
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
Kurkowska-Jastrzębska, I., Litwin, T., Joniec, I., Ciesielska, A., Przybyłkowski, A., Członkowski, A., & Członkowska, A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.006 · Cited by 117
Bossù, P., Ciaramella, A., Salani, F., Bizzoni, F., Varsi, E., Di Iulio, F., Giubilei, F., Gianni, W., Trequattrini, A., Moro, M. L., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.10.001 · Cited by 116 · cited 1×
“…correlate with global cognitive performance in AD patients (i.e., MMSE), suggesting that worse overall cognition is associated with higher levels of peripheral inflammatory markers (Bonotis et al., 2008; Bossu et al., 2008; Forlenza et al., 2009; Licastro et al., 2000; Tarkowski et al., 2003).”
The Role of Anti-Inflammatory Agents in Parkinson???s Disease
McGeer, E. G., & McGeer, P. L. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00001 · Cited by 95
Marioni, R. E., Stewart, M. C., Murray, G. D., Deary, I. J., Fowkes, F. G. R., Lowe, G. D. O., Rumley, A., & Price, J. F. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181b1e538 · Cited by 86 · cited 2×
“In addition to impoverished memory profiles, inflammatory markers have also been shown to negatively correlate with measures of executive functions and processing speed in functionally normal older adults (Marioni et al., 2009; Marsland et al., 2006).”
Rentzos, M., Zoga, M., Paraskevas, G. P., Kapaki, E., Rombos, A., Nikolaou, C., Tsoutsou, A., & Vassilopoulos, D. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706286226 · Cited by 65
Öztürk, C., Özge, A., Yalın, O. Ö., Yılmaz, İ. A., Delialioglu, N., Yıldız, Ç., Tesdelen, B., & Kudiaki, C. (2007) · Behavioural Neurology · doi:10.1155/2007/432190 · Cited by 46 · cited 3×
“…underscore, however, that additional cross-sectional studies report no significant correlations between inflammation and MMSE (Olgiati et al., 2010; Ozturk et al., 2007; Popp et al., 2009), positive correlations (Kim et al., 2008; Sala et al., 2003), or report associations only with specific…”
APOE epsilon-4 allele and cytokine production in Alzheimer's disease
Olgiati, P., Politis, A., Malitas, P., Albani, D., Dusi, S., Polito, L., De Mauro, S., Zisaki, A., Piperi, C., Stamouli, E., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2344 · Cited by 35 · cited 10×
“For example, Sala et al. (2003) reported a positive relationship between MMSE and three pro-inflammatory markers, including IL-1, IL-6, and TNF-α, and interpreted these findings as preliminary evidence for downregulation of inflammation in late clinical stages of the disease.”
InfluentialInflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · cited 3×
“Associations between baseline peripheral levels of IL-6 and CRP (Engelhart et al., 2004), as well as baseline production of IL-1 and TNF-α (Tan et al., 2007) and future development of AD have been corroborated in other prospective cohort studies, suggesting that elevations in inflammatory mediators…”
Cited by
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice
Yang, X., Yu, D., Xue, L., Li, H., & Du, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.001 · Cited by 407
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
Bettcher, B. M., Fitch, R., Wynn, M. J., Lalli, M. A., Elofson, J., Jastrzab, L., Mitic, L., Miller, Z. A., Rabinovici, G. D., Miller, B. L., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.05.004 · Cited by 89
Self-citationPharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
Deng, Z., Dong, Y., Zhou, X., Lu, J.-H., & Yue, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.009 · Cited by 58
Metadata
- Authors
- Bettcher, B. M., & Kramer, J. H.
- Venue
- Neurocase
- Publisher
- Informa UK Limited
- Published
- 2013-04
- Volume
- 19
- Issue
- 2
- Pages
- 182-200
- ISSN
- 1355-4794 (ISSN-L)
- 1465-3656
- OpenAlex
- W2055857680
- Cited by
- 47
- References
- 53
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.